Ascend Wellness (OTCMKTS:AAWH) Rating Increased to Hold at Zacks Research

Zacks Research upgraded shares of Ascend Wellness (OTCMKTS:AAWH) from a strong sell rating to a hold rating in a research report released on Tuesday morning,Zacks.com reports.

Ascend Wellness Trading Up 3.6%

Shares of AAWH stock opened at $0.57 on Tuesday. Ascend Wellness has a 1 year low of $0.26 and a 1 year high of $1.20. The firm has a fifty day moving average price of $0.51 and a 200-day moving average price of $0.59. The company has a debt-to-equity ratio of 133.34, a current ratio of 1.92 and a quick ratio of 1.14. The company has a market cap of $115.27 million, a price-to-earnings ratio of -0.98 and a beta of 1.22.

Ascend Wellness (OTCMKTS:AAWH) last issued its quarterly earnings data on Wednesday, May 13th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.13) by ($0.02). Ascend Wellness had a negative net margin of 23.61% and a negative return on equity of 1,099.51%. As a group, equities analysts predict that Ascend Wellness will post -0.32 earnings per share for the current year.

About Ascend Wellness

Ascend Wellness Holdings, Inc engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States. The company offers flower, pre-rolls, concentrates, vapes, edibles, tinctures, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Ozone Reserve, Royale, Tunnel Vision, Miss Grass, Lowell Smokes, Edie Parker, 1906, and AiroPro brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores and third-party licensed retail cannabis stores.